Cigna Co. (NYSE:CI) Shares Purchased by Alliancebernstein L.P.

Alliancebernstein L.P. raised its holdings in shares of Cigna Co. (NYSE:CI) by 10.4% in the third quarter, Holdings Channel.com reports. The institutional investor owned 1,277,730 shares of the health services provider’s stock after purchasing an additional 120,847 shares during the quarter. Alliancebernstein L.P.’s holdings in Cigna were worth $255,750,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the company. Townsend & Associates Inc acquired a new position in Cigna in the third quarter valued at about $1,523,000. AQR Capital Management LLC lifted its position in shares of Cigna by 47.6% during the second quarter. AQR Capital Management LLC now owns 176,883 shares of the health services provider’s stock worth $41,934,000 after purchasing an additional 57,069 shares in the last quarter. Private Advisor Group LLC lifted its position in shares of Cigna by 27.3% during the third quarter. Private Advisor Group LLC now owns 15,899 shares of the health services provider’s stock worth $3,182,000 after purchasing an additional 3,410 shares in the last quarter. Heritage Investors Management Corp lifted its position in shares of Cigna by 33.5% during the third quarter. Heritage Investors Management Corp now owns 15,180 shares of the health services provider’s stock worth $3,038,000 after purchasing an additional 3,805 shares in the last quarter. Finally, DNB Asset Management AS increased its stake in shares of Cigna by 6.9% during the third quarter. DNB Asset Management AS now owns 130,906 shares of the health services provider’s stock worth $26,202,000 after buying an additional 8,412 shares during the period. 86.34% of the stock is currently owned by hedge funds and other institutional investors.

In other Cigna news, EVP Everett Neville sold 4,800 shares of the business’s stock in a transaction on Monday, January 3rd. The stock was sold at an average price of $229.49, for a total transaction of $1,101,552.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.80% of the company’s stock.

A number of analysts recently weighed in on CI shares. The Goldman Sachs Group started coverage on shares of Cigna in a research note on Tuesday, December 14th. They set a “neutral” rating and a $233.00 target price on the stock. Seaport Research Partners began coverage on shares of Cigna in a research note on Wednesday, November 17th. They issued a “buy” rating and a $270.00 price target on the stock. Seaport Res Ptn reiterated a “buy” rating on shares of Cigna in a research note on Wednesday, November 17th. Credit Suisse Group raised their target price on shares of Cigna from $270.00 to $300.00 and gave the stock an “outperform” rating in a research report on Monday, November 8th. Finally, UBS Group lowered their target price on shares of Cigna from $285.00 to $244.00 and set a “buy” rating on the stock in a research report on Monday, October 11th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $262.04.

Shares of CI opened at $240.55 on Friday. The company has a market cap of $79.73 billion, a P/E ratio of 10.11, a PEG ratio of 0.95 and a beta of 0.91. The stock has a fifty day moving average price of $218.59 and a 200 day moving average price of $216.95. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.49 and a quick ratio of 0.49. Cigna Co. has a 12 month low of $191.74 and a 12 month high of $272.81.

Cigna (NYSE:CI) last issued its quarterly earnings data on Thursday, November 4th. The health services provider reported $5.73 EPS for the quarter, topping the Zacks’ consensus estimate of $5.23 by $0.50. The firm had revenue of $44.30 billion during the quarter, compared to the consensus estimate of $42.88 billion. Cigna had a return on equity of 13.72% and a net margin of 4.93%. The firm’s revenue was up 8.6% on a year-over-year basis. During the same period in the prior year, the business earned $4.41 EPS. As a group, research analysts anticipate that Cigna Co. will post 20.41 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 22nd. Shareholders of record on Tuesday, December 7th were given a dividend of $1.00 per share. The ex-dividend date was Monday, December 6th. This represents a $4.00 dividend on an annualized basis and a yield of 1.66%. Cigna’s dividend payout ratio (DPR) is presently 16.81%.

Cigna Company Profile

Cigna Corp. engages in the provision of global health services. It operates through the following segments: Evernorth, U.S. Medical, International Markets, and Group Disability and Other. The Evernorth segment includes a broad range of coordinated and point solution health services, including pharmacy solutions, benefits management solutions, care solutions and intelligence solutions.

Featured Article: How does a reverse stock split work?

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Co. (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.